Elsa Tynell

655 total citations
16 papers, 496 citations indexed

About

Elsa Tynell is a scholar working on Epidemiology, Management of Technology and Innovation and Infectious Diseases. According to data from OpenAlex, Elsa Tynell has authored 16 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Management of Technology and Innovation and 5 papers in Infectious Diseases. Recurrent topics in Elsa Tynell's work include Blood donation and transfusion practices (6 papers), Blood transfusion and management (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Elsa Tynell is often cited by papers focused on Blood donation and transfusion practices (6 papers), Blood transfusion and management (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Elsa Tynell collaborates with scholars based in Sweden, United Kingdom and Denmark. Elsa Tynell's co-authors include Rut Norda, Olof Åkerblom, Anders Björkman, Christer Lidman, Agneta Shanwell, Börje Åkerlund, Alan B. Rickinson, Q. Y. Yao, Marsha Wood and Elisabeth Aurelius and has published in prestigious journals such as The Journal of Infectious Diseases, AIDS and Transfusion.

In The Last Decade

Elsa Tynell

16 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elsa Tynell Sweden 11 180 129 105 105 96 16 496
Jochewed Werch United States 12 433 2.4× 101 0.8× 74 0.7× 70 0.7× 29 0.3× 18 716
Barbee Whitaker United States 12 77 0.4× 281 2.2× 182 1.7× 58 0.6× 111 1.2× 44 529
Nancy L. Van Buren United States 9 74 0.4× 150 1.2× 59 0.6× 45 0.4× 134 1.4× 17 438
Purabi Deka Bose India 9 89 0.5× 19 0.1× 15 0.1× 116 1.1× 48 0.5× 20 673
Gemma Ramírez Spain 9 34 0.2× 64 0.5× 20 0.2× 47 0.4× 42 0.4× 19 262
Sarah L. Morley United Kingdom 10 182 1.0× 143 1.1× 47 0.4× 19 0.2× 67 0.7× 19 513
Fikir Asrie Ethiopia 13 63 0.3× 37 0.3× 100 1.0× 82 0.8× 5 0.1× 31 503
Danielle Rebibo France 10 47 0.3× 339 2.6× 228 2.2× 9 0.1× 166 1.7× 20 482
Meghan Fitzpatrick United States 14 305 1.7× 44 0.3× 6 0.1× 176 1.7× 30 0.3× 31 553
Consuelo Climent Puerto Rico 14 75 0.4× 18 0.1× 21 0.2× 135 1.3× 7 0.1× 33 535

Countries citing papers authored by Elsa Tynell

Since Specialization
Citations

This map shows the geographic impact of Elsa Tynell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsa Tynell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsa Tynell more than expected).

Fields of papers citing papers by Elsa Tynell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elsa Tynell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsa Tynell. The network helps show where Elsa Tynell may publish in the future.

Co-authorship network of co-authors of Elsa Tynell

This figure shows the co-authorship network connecting the top 25 collaborators of Elsa Tynell. A scholar is included among the top collaborators of Elsa Tynell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elsa Tynell. Elsa Tynell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tynell, Elsa, et al.. (2012). [Typical symptoms for tularemia without a typical medical history].. PubMed. 109(23-24). 1172–3. 1 indexed citations
2.
Tynell, Elsa, Therése Andersson, Rut Norda, et al.. (2010). Should plasma from female donors be avoided? A population‐based cohort study of plasma recipients in Sweden from 1990 through 2002. Transfusion. 50(6). 1249–1256. 21 indexed citations
3.
Kamper‐Jørgensen, Mads, Martin Ahlgren, Klaus Rostgaard, et al.. (2008). Survival after blood transfusion. Transfusion. 48(12). 2577–2584. 67 indexed citations
4.
Norda, Rut & Elsa Tynell. (2007). Use of plasma: Clinical indications and types of plasma components in Sweden. Transfusion Clinique et Biologique. 14(6). 560–563. 4 indexed citations
5.
Norda, Rut, Elsa Tynell, & Olof Åkerblom. (2006). Cumulative Risks of Early Fresh Frozen Plasma, Cryoprecipitate and Platelet Transfusion in Europe. The Journal of Trauma: Injury, Infection, and Critical Care. 60(6). S41–S45. 111 indexed citations
6.
Tynell, Elsa, Rut Norda, Bengt Ekermo, et al.. (2006). False‐reactive microbiologic screening test results in Swedish blood donors—how big is the problem? A survey among blood centers and deferred donors. Transfusion. 47(1). 80–89. 27 indexed citations
7.
Tynell, Elsa, Rut Norda, Scott Montgomery, & Anders Björkman. (2005). Diagnosis and procedure‐specific survival among transfusion of recipients in 1993 and 2000, Örebro County, Sweden. Vox Sanguinis. 88(3). 181–188. 11 indexed citations
8.
Tynell, Elsa, Rut Norda, Agneta Shanwell, & Anders Björkman. (2001). Long‐term survival in transfusion recipients in Sweden, 1993. Transfusion. 41(2). 251–255. 32 indexed citations
9.
Tynell, Elsa, Anders Björkman, & Rut Norda. (2001). Reply. Transfusion. 41(9). 1174–1176. 2 indexed citations
10.
Tynell, Elsa, Sören Andersson, M Arneborn, et al.. (1998). Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis. BMJ. 316(7142). 1417–1422. 37 indexed citations
12.
Tynell, Elsa, Elisabeth Aurelius, Inger Julander, et al.. (1996). Acyclovir and Prednisolone Treatment of Acute Infectious Mononucleosis: A Multicenter, Double-Blind, Placebo-Controlled Study. The Journal of Infectious Diseases. 174(2). 324–331. 109 indexed citations
13.
Elvin, Kerstin, Christer Lidman, Elsa Tynell, Ewert Linder, & Anders Björkman. (1994). Natural History of Asymptomatic and Symptomatic Pneumocystis carinii Infection in HIV Infected Patients. Scandinavian Journal of Infectious Diseases. 26(6). 643–651. 7 indexed citations
14.
Lidman, Christer, Ove Berglund, Elsa Tynell, Stefan Lindbäck, & Kerstin Elvin. (1994). Aerosolized pentamidine as primary prophylaxis for Pneumocystis carinii pneumonia. AIDS. 8(7). 935–940. 9 indexed citations
15.
Lidman, Christer, Ove Berglund, Stefan Lindbäck, & Elsa Tynell. (1993). Aerosolized pentamidine versus i. v. pentamidine for secondary prophylaxis ofPneumocystis carinii pneumonia. Infection. 21(3). 146–149. 10 indexed citations
16.
Lidman, Christer, Ove Berglund, Elsa Tynell, & Stefan Lindbäck. (1992). CD4+ Cells and CD4 + Percent as Risk Markers for Pneumocystis carinii Pneumonia (PCP): Implications for Primary PCP Prophylaxis. Scandinavian Journal of Infectious Diseases. 24(2). 157–160. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026